SYNAPTIC PHARMACEUTICALS
Synaptic Pharmaceutical Corporation develops human receptor-targeted drug design technology. The Company offers technology which is used to discover and clone the genes that code for human receptor subtypes that may be associated with specific disorders.
SYNAPTIC PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Address:
Paramus, New Jersey, United States
Country:
United States
Status:
Active
Contact:
(201)261-1331
Similar Organizations
Addrenex Pharmaceuticals
Addrenex Pharmaceuticals develops drugs to regulate the adrenergic system.
Artenga
Artenga is a platform for drug delivery technology.
Axxia Pharmaceuticals
Axxia Pharmaceuticals provides implantable polymeric drug delivery technologies.
Integrative Enzymatics
Integrative Enzymatics has developed a proprietary method of designing pharmaceuticals.
Semafore Pharmaceuticals
Semafore Pharmaceuticals discovers and develops clinical-stage drugs.
Sustained Nano Systems
Sustained Nano Systems is a provider of nanoparticle-based drug delivery technology.
Talon Pharmaceuticals
Talon Pharmaceuticals is a multiphore drug design platform.
More informations about "Synaptic Pharmaceuticals"
Synaptic Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Synaptic Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 news, and 2 literature, Disease Domain:Nervous System Diseases, Technology …See details»
Synaptic Pharmaceuticals Corp - Company Profile and News
Company profile page for Synaptic Pharmaceuticals Corp including stock price, company news, executives, board members, and contact informationSee details»
Lundbeck acquires Synaptic Pharmaceuticals - 2002-11-21
Synaptic Pharmaceuticals Synaptic Pharmaceuticals develops human receptor-targeted drug design technology. Acquiring Organization: Lundbeck Lundbeck is a pharmaceutical company …See details»
Synaptic Pharmaceutical - Products, Competitors, Financials, …
Dec 13, 1995 Synaptic Pharmaceutical was founded in 1987. Where is Synaptic Pharmaceutical's headquarters? Synaptic Pharmaceutical's headquarters is located at 215 …See details»
SNAP-5114 - Drug Targets, Indications, Patents - Synapse
Abstract Normalization of the excitatory and inhibitory balance by increasing the levels of endogenous inhibitory neurotransmitters by blocking their reuptake is a promising therapeutic …See details»
Synaptic Pharmaceutical Corporation - Products, Competitors, …
Details from the Umecrine Cognition press release follow: Dr. Thomas P. Blackburn brings more than 40 years of experience in the pharmaceutical and biotechnology sectors, where he has …See details»
SYNAPTIC PHARMACEUTICAL CORP - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYNAPTIC PHARMACEUTICAL CORP of Paramus, NJ. Get the latest business insights from Dun & …See details»
Synaptic Pharmaceuticals - Crunchbase
Synaptic Pharmaceuticals develops human receptor-targeted drug design technology.See details»
Synaptics Pharmaceuticals | Profile | The Company Check
Jul 26, 2024 Synaptics Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2018 (Six years 25 days old ). …See details»
Lundbeck buys Synaptic for $121m - Manufacturing Chemist
Jan 1, 2003 Danish pharmaceutical company H. Lundbeck has agreed to purchase US-based Synaptic Pharmaceutical Corporation for US$121m (Euro 119m), subject to approvals. …See details»
Home - Synaptic Medical
Synaptic’s mission is to create a platform that inspires and supports team members to grow while improving arrhythmia and related disease outcomes in a holistic and socially responsible manner. Excellence in cardiac electrophysiology. Safety This is not our priority, but our mandate.See details»
Lundbeck Acquiring Synaptic, CNS Pipeline For $121M In Cash
Nov 22, 2002 Synaptic Pharmaceutical Corp. signed a definitive merger agreement with like-minded central nervous system-focused H. Lundbeck A/S in a deal worth about $121 million. …See details»
Synaptic Pharmaceutical Corporation - CB Insights
Explore {Synaptic Pharmaceutical Corporation's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Cellular Migration in the Central Nervous System | The antibody …
Creative Biolabs introduces the processes of neural development from neural induction through synaptic refinement and puts them in a podcast column for interested researchers. ... The …See details»
Syntex Pharmaceuticals Ltd. - Drug pipelines, Patents, Clinical …
Prior to this, he held positions related to R&D and regulatory affairs at Alcon Research-Novartis, Synaptic Pharmaceutical Corp, and Syntex Pharma / Roche Pharmaceutical Corp. He is widely published with an extensive number of peer-reviewed publications, edited books and holds multiple patents for mitigation of neurological and ophthalmic diseases.See details»
SNAP-7941 - Drug Targets, Indications, Patents - Synapse
2 days ago The MCHR1 is an interesting pharmacological and pharmaceutical target, due to its involvement in pathologies as diabetes, gut inflammation and adiposity. in vivo PET-studies of …See details»
SYNAPTIC PHARMACEUTICAL CORP Top 13F Holdings
Synaptic Pharmaceutical Corporation is a drug discovery company using its proprietary portfolio of G protein-coupled receptors (GPCRs) as the basis for developing new drugs for the treatment of a variety of human disorders. GPCRs represent a family of human receptors that are involved with a broad range of physiological functions in the body.See details»
Synaptic Pharmaceuticals - Updates, News, Events, Signals
Synaptic Pharmaceuticals develops human receptor-targeted drug design technology.See details»
Synaptic Pharmaceuticals - LinkedIn
Synaptic Pharmaceutical is a well-established pharmaceutical company with a presence across Pakistan. With nearly 20 years of presence in the industry, we specialize in psychiatry products.See details»